Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Issa

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Cancer|October 2, 2009
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalitiesFarhad Ravandi, Jean-Pierre Issa, Guillermo Garcia-Manero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomasDavid J Stewart, Jean-Pierre Issa, Razelle Kurzrock, et al.
Cancer|February 23, 2007
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experienceHagop M Kantarjian, Susan O'Brien, Xuelin Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancerStephane Temam, Hidetoshi Kawaguchi, Adel K El-Naggar, et al.
Cancer|August 20, 2009
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Epigenetic regulation of ARHI in breast and ovarian cancer cellsYinhua Yu, Satoshi Fujii, Jiuhong Yuan, et al.
Epigenetics|May 8, 2009
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumorsAna Aparicio, Brittany North, Lindsey Barske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian menBernard Kwabi-Addo, Songping Wang, Woonbok Chung, et al.
Nature Neuroscience|November 10, 2015
G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transitionGeoffroy Laumet, Judit Garriga, Shao-Rui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylationJean-Charles Soria, Ho-Young Lee, Janet I Lee, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Cancer|October 2, 2009
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalitiesFarhad Ravandi, Jean-Pierre Issa, Guillermo Garcia-Manero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomasDavid J Stewart, Jean-Pierre Issa, Razelle Kurzrock, et al.
Cancer|February 23, 2007
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experienceHagop M Kantarjian, Susan O'Brien, Xuelin Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancerStephane Temam, Hidetoshi Kawaguchi, Adel K El-Naggar, et al.
Cancer|August 20, 2009
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Epigenetic regulation of ARHI in breast and ovarian cancer cellsYinhua Yu, Satoshi Fujii, Jiuhong Yuan, et al.
Epigenetics|May 8, 2009
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumorsAna Aparicio, Brittany North, Lindsey Barske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian menBernard Kwabi-Addo, Songping Wang, Woonbok Chung, et al.
Nature Neuroscience|November 10, 2015
G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transitionGeoffroy Laumet, Judit Garriga, Shao-Rui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylationJean-Charles Soria, Ho-Young Lee, Janet I Lee, et al.
Pageof 10